Basic Information
Heartseed Aims to Develop and Commercialize Cardiac Regenerative Drugs Created by Professor Keiichi Fukuda and His Team in the Department of Cardiology at Keio University in Tokyo. Heartseed possesses original technology throughout the entire process of manufacturing and providing iPSC-derived cardiac regenerative drugs, including purification, cell delivery, and iPSC production.
Heartseed, Inc.
Tokyo,Tokyo,Japan
15~50 people
January 01, 2015
contact@heartseed.jp
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios